Post Healthcare Reform, not solely are Government Programs in an exceedingly seemingly constant state of flux, however several of the foremost sophisticated programs are in an exceedingly regulatory vacuum amount we all know one thing is returning down the pipe, however haven't any plan when and the way it'll have an effect on us.So what will we have a tendency to do to help? At the govt. Programs Summit, we have a tendency to collect each the key government officers who offers the foremost clarity regarding what to try and do currently to arrange for what might come back LATER and leading pharmaceutical and generic manufacturer executives who can leave you with sensible data on how they're managing the uncertainty.
In two short days you will:
- - Have unparalleled access to CMS authorities from the Policy, Technical, and Operations Departments, in the session, “CMS AMP Guidance Answers and Next Steps for Medicaid Drug Rebate Program,” as well as the opportunity for one on one, personalized attention in the CMS meeting room.
- - Get an update on 340B guidance directly from HRSA officers, including definitions of “Eligible Patient” under the PHS program in the session, “340B PHS Guidance, Definitions and Oversight Update.”
- - Learn to accrue for the potential 4 million new beneficiaries to Medicare Part D who may fall in to the Donut Hole in 2012 in the session, “Medicare Part D for the Donut Hole: Guidance Updates, Invoicing, Disputes and Appeals Processes.”
Staying up to date on current proposed rules, interpretations, and implementations of government programs is of paramount importance to branded and generic manufactures.
Government Programs and Pricing Compliance Summit will take place March 7-9, 2012, in Baltimore, Maryland. For more information on the program, download the brochure here.
